Athena Asks Fed. Circ. To Revive Nixed Biotech Patent

By Chuck Stanley · October 4, 2018, 5:33 PM EDT

Athena Diagnostics and Oxford University Innovation Ltd. on Thursday asked a Federal Circuit panel to revive their patent for a test that diagnoses an autoimmune disease based on the presence of...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

Athena Diagnostics, Inc. v. Mayo Collaborative Services

Case Number

Court

Appellate - Federal Circuit

Nature of Suit

830 Patent Infringement (Fed. Question)

Date Filed

September 05, 2017

Recent Articles By Chuck

October 26, 2018
Too Late To Stop Bargain Bin Health Plans, Judge Says
October 23, 2018
Couple Says Gov't 'Ambush' Led To Fraud Convictions
August 16, 2018
Antitrust Suit Against Walgreens, Benefits Manager Tossed
August 13, 2018
Fed. Circ. Wrong On HIV Drug Patent Challenge, Justices Hear
August 06, 2018
Dental Cos. Look to Straighten Patent Row In Fed. Circ.
July 11, 2018
FCC Announces $100M Telehealth Pilot Program
June 14, 2018
Aggrenox Buyers Slam Insurers' Bid To Opt Health Plans Out
June 13, 2018
BCBS Can Appeal Ruling That Limits Antitrust MDL Defense
May 24, 2018
Teledentistry Co. Hits Ga. Dentistry Board With Antitrust Suit
May 21, 2018
Highmark Fights Cert. In Antitrust Suit Over Insurance Rates